Review
Genotoxicity of arsenical compounds

https://doi.org/10.1078/S1438-4639(04)70036-XGet rights and content

Abstract

With respect to global human health hazard, arsenic (As) is one of the most important environmental single substance toxicants. Currently, millions of people all over the world are exposed to the ubiquitous element in exposure levels leading to long-term toxicity, in particular cancer. Unfortunately, it has not been elucidated up to now how As mechanistically leads to the induction of neoplasia. Besides its tumorigenic potential, As has been shown to be genotoxic in a wide variety of different experimental set-ups and biological endpoints. In vitro, the element was shown to induce chromosomal muta-genicity like micronuclei, chromosome aberrations, and sister chromatid exchanges. It mainly acts clastogenic but also has an aneugenic potential. Instead, its potential to induce point mutations is very low in bacterial as well as in mammalian cell systems. However, in combined exposure with point mutagens in vitro, As was shown to enhance the frequency of chemical mutations in a synergistic manner. Additionally, As was shown to induce chromosome aberrations and micronuclei in vivo in experiments with mice. After long-term exposure to As-contaminated drinking water, the great majority of human biomonitoring studies found elevated frequencies of DNA lesions like micronuclei or chromosome aberrations. Respective occupational studies are few. Like it is the case for As car-cinogenicity, it is not known through which mechanism the genotoxicity of As is mediated, although the data available indicate that As may act indirectly on DNA, i. e. via mechanisms like interference of regulation of DNA repair or integrity.

Because of the indirect mode of action, it has been discussed as well that As's genotoxicity may underlie a sublinear dose-response relationship. However, various problems like non-standardized test systems and experimental variability make it impossible to prove such statement. Basically, to be able to improve risk assessment, it is of crucial importance to scientifically approach the mechanistic way of induction of As's genotoxicity and carcinogenicity.

References (101)

  • H.K. Hamadeh et al.

    Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis

    Biochem. Biophys. Res. Commun.

    (1999)
  • K. Harrington-Brock et al.

    Effects of arsenic exposure on the frequency of HPRT-mutant lymphocytes in a population of copper roasters in Antofagasta, Chile: a pilot study

    Mutat. Res.

    (1999)
  • L.L. Hsieh et al.

    Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations

    Cancer Lett.

    (1994)
  • Y. Hu et al.

    Arsenic toxicity is enzyme specific and its effects on ligation are not caused by the direct inhibition of DNA repair enzymes

    Mutat. Res.

    (1998)
  • A.N. Jha et al.

    Genotoxic effects of sodium arsenite on human cells

    Mutat. Res.

    (1992)
  • E. Kashiwada et al.

    Aneuploidy induced by dimethylarsinic acid in mouse bone marrow cells

    Mutat. Res.

    (1998)
  • T.S. Kochhar et al.

    Effect of trivalent and pentavalent arsenic in causing chromosome alterations in cultured Chinese hamster ovary (CHO) cells

    Toxicol Lett.

    (1996)
  • H. Lantzsch et al.

    Genotoxicity of selected metal compounds in the SOS chromotest

    Mutat. Res.

    (1997)
  • T.C. Lee et al.

    Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanineresistant mutagenicity of ultraviolet light in Chinese hamster ovary cells

    Mutat. Res.

    (1985)
  • D. Lerda

    Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water

    Mutat. Res.

    (1994)
  • S.A. Lerman et al.

    Arsenic uptake and metabolism by liver cells is dependent on arsenic oxidation state

    Chem.-Biol. Interact.

    (1983)
  • M.J. Mass et al.

    Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis

    Mutat. Res.

    (1997)
  • M. Matsui et al.

    The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy–2'-deoxyguanosine in arsenicrelated Bowen's disease

    J. Invest. Dermatol.

    (1999)
  • M.M. Moore et al.

    Relative genotoxic potency of arsenic and its methylated metabolites

    Mutat. Res.

    (1997)
  • K. Nakamuro et al.

    Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic

    Mutat. Res.

    (1981)
  • P. Ostrosky-Wegman et al.

    Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico

    Mutat. Res.

    (1991)
  • Y. Oya-Ohta et al.

    Induction of chromosomal aberrations in cultured human fibroblasts by inorganic and organic arsenic compounds and the different roles of glutathione in such induction

    Mutat. Res.

    (1996)
  • J.S. Petrick et al.

    Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes

    Toxicol. Appl. Pharmacol.

    (2000)
  • D.J.H. Phillips

    Arsenic in aquatic organisms: a review, emphasizing chemical speciation

    Aquat. Toxicol.

    (1990)
  • P. Ramirez et al.

    Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide

    Mutat. Res.

    (1997)
  • R.E. Rasmussen et al.

    Variation in arsenicinduced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines

    Mutat. Res.

    (1997)
  • A. RoyChoudhury et al.

    Dietary garlic extract in modifying clastogenic effects of inorganic arsenic in mice: two-generation studies

    Mutat. Res.

    (1996)
  • R. Rudel et al.

    Implications of arsenic genotoxicity for dose response of carcinogenic effects

    Regul. Toxicol. Pharmacol.

    (1996)
  • R.R. Tice et al.

    Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite

    Mutat. Res.

    (1997)
  • T.S. Wang et al.

    Glutathione peroxidase and catalase modulate the genotoxicity of arsenite

    Toxicology

    (1997)
  • J.W. Yager et al.

    Inhibition of poly(ADP-ribose) polymerase by arsenite

    Mutat. Res.

    (1997)
  • S. Yamamoto et al.

    Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review

    Mutat. Res.

    (1997)
  • K. Yamanaka et al.

    Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice

    Biochem. Biophys. Res. Commun.

    (1989)
  • K. Yamanaka et al.

    Crosslink formation between DNA and nuclear proteins by in vivo and in vitro exposure of cells to dimethylarsinic acid

    Biochem. Biophys. Res. Commun.

    (1993)
  • H. Yamauchi et al.

    Metabolism and excretion of orally administered dimethylarsinic acid in the hamster

    Toxicol. Appl. Pharmacol.

    (1984)
  • ATSDR (Agency for Toxic Substances and Disease Registry) http://www.atsdr.cdc.gov...
  • G. Beckman et al.

    Chromosome aberrations in workers exposed to arsenic

    Environ. Health Perspect

    (1977)
  • K. Castren et al.

    Infrequent p53 mutations in arsenic-related skin lesions

    Oncol. Res.

    (1998)
  • W.R. Cullen et al.

    Arsenic speciation in the Environment

    Chem. Rev.

    (1989)
  • T. Das et al.

    Modification of clastogenicity of three known clastogens by garlic extract in mice in vivo

    Environ. Mol. Mutagen.

    (1993)
  • G. Deknudt et al.

    In vivo studies in male mice on the mutagenic effects of inorganic arsenic

    Mutagenesis

    (1986)
  • D.A. Eastmond et al.

    Identification of aneuploidyinducing agents using cytokinesis-blocked human lymphocytes and an anti-kinetochore antibody

    Environ. Mol. Mutagen.

    (1989)
  • N. Eguchi et al.

    Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells

    Arch. Environ. Contam. Toxicol.

    (1997)
  • T. Gebel et al.

    Comparative and environmental genotoxicity of antimony and arsenic

    Anticancer Res.

    (1997)
  • P. Hantson et al.

    Sister chromatid exchanges in human peripheral blood lymphocytes after ingestion of high doses of arsenicals

    Int. Arch. Occup. Environ. Health

    (1996)
  • Cited by (0)

    View full text